• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ERG 调控的 14-3-3ε-FOXO 通路促进前列腺癌细胞存活。

The ERG-Regulated Promotes Prostate Cancer Cell Survival via the 14-3-3ε-FOXO Pathway.

机构信息

Division of Cancer Genome Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.

出版信息

Mol Cancer Res. 2020 Oct;18(10):1545-1559. doi: 10.1158/1541-7786.MCR-20-0021. Epub 2020 Jul 9.

DOI:10.1158/1541-7786.MCR-20-0021
PMID:32646965
Abstract

Numerous noncoding transcripts have been reported to correlate with cancer development and progression. Nevertheless, there remains a paucity of long noncoding RNAs (lncRNA) with well-elucidated functional roles. Here, we leverage the International Cancer Genome Consortium-Early Onset Prostate Cancer transcriptome and identify the previously uncharacterized lncRNA to be upregulated in prostate tumors. Phenotypic characterization of revealed its positive impact on cellular proliferation, colony formation, and migration. We demonstrate that transcription is directly activated by ERG, an oncogenic transcription factor overexpressed in 50% of prostate cancers. Chromatin isolation by RNA purification-mass spectrometry revealed the interaction of with the 14-3-3ε protein, leading to enhanced sequestration of tumor suppressive FOXO1. Altogether, our results provide a rationale on how ERG overexpression, partly by driving transcription, could confer survival advantage to prostate cancer cells and potentially prime PTEN-intact prostate cells for cellular transformation through FOXO inactivation. IMPLICATIONS: The study describes a novel lncRNA-mediated mechanism of regulating the FOXO signaling pathway and provides additional insight into the role of ERG in prostate cancer cells.

摘要

大量的非编码转录本已被报道与癌症的发生和发展相关。然而,具有明确功能作用的长非编码 RNA(lncRNA)仍然很少。在这里,我们利用国际癌症基因组联合会-早发性前列腺癌转录组,鉴定出以前未被描述的 lncRNA 在前列腺肿瘤中上调。对 的表型特征分析表明,它对细胞增殖、集落形成和迁移有积极影响。我们证明,转录因子 ERG(一种在 50%的前列腺癌中过表达的致癌转录因子)可直接激活 。RNA 纯化-质谱法的染色质分离揭示了 与 14-3-3ε 蛋白的相互作用,导致肿瘤抑制因子 FOXO1 的封闭增强。总之,我们的研究结果提供了一个合理的机制,说明 ERG 过表达如何通过驱动 转录,为前列腺癌细胞提供生存优势,并通过 FOXO 失活使 PTEN 完整的前列腺细胞潜在地为细胞转化做好准备。意义:该研究描述了一种新的 lncRNA 调节 FOXO 信号通路的机制,并为 ERG 在前列腺癌细胞中的作用提供了更多的见解。

相似文献

1
The ERG-Regulated Promotes Prostate Cancer Cell Survival via the 14-3-3ε-FOXO Pathway.ERG 调控的 14-3-3ε-FOXO 通路促进前列腺癌细胞存活。
Mol Cancer Res. 2020 Oct;18(10):1545-1559. doi: 10.1158/1541-7786.MCR-20-0021. Epub 2020 Jul 9.
2
Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.FOXO1缺失与TMPRSS2-ERG过表达协同作用促进前列腺肿瘤发生和细胞侵袭。
Cancer Res. 2017 Dec 1;77(23):6524-6537. doi: 10.1158/0008-5472.CAN-17-0686. Epub 2017 Oct 6.
3
Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.前列腺癌中 ERG 调控的激酶组学特征分析鉴定 TNIK 为潜在治疗靶点。
Neoplasia. 2019 Apr;21(4):389-400. doi: 10.1016/j.neo.2019.02.005. Epub 2019 Mar 20.
4
Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.PI3K/AKT、PTEN/FOXO 和 AR 信号在前列腺癌中的相互作用。
Adv Exp Med Biol. 2019;1210:319-331. doi: 10.1007/978-3-030-32656-2_14.
5
Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2.致癌 ERG 通过下调 IRS2 抑制 PI3K 信号通路。
Cancer Res. 2020 Apr 1;80(7):1428-1437. doi: 10.1158/0008-5472.CAN-19-1394. Epub 2020 Feb 3.
6
Phosphorylation of the oncogenic transcription factor ERG in prostate cells dissociates polycomb repressive complex 2, allowing target gene activation.前列腺细胞中致癌转录因子ERG的磷酸化使多梳抑制复合物2解离,从而激活靶基因。
J Biol Chem. 2017 Oct 20;292(42):17225-17235. doi: 10.1074/jbc.M117.796458. Epub 2017 Sep 8.
7
Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.miR-153 的上调通过下调抑癌基因 PTEN 促进人前列腺癌细胞的增殖。
Prostate. 2013 May;73(6):596-604. doi: 10.1002/pros.22600. Epub 2012 Oct 11.
8
Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.抑制 BRD4 通过增强 FOXO1 表达抑制前列腺癌肿瘤生长。
Int J Oncol. 2018 Dec;53(6):2503-2517. doi: 10.3892/ijo.2018.4577. Epub 2018 Sep 27.
9
FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.FOXO蛋白调节肿瘤坏死因子相关凋亡诱导配体的表达。对前列腺癌中PTEN突变的影响。
J Biol Chem. 2002 Dec 6;277(49):47928-37. doi: 10.1074/jbc.M207509200. Epub 2002 Sep 25.
10
DNA Promoter Methylation and ERG Regulate the Expression of CD24 in Prostate Cancer.DNA 启动子甲基化和 ERG 调控前列腺癌中 CD24 的表达。
Am J Pathol. 2021 Apr;191(4):618-630. doi: 10.1016/j.ajpath.2020.12.014. Epub 2021 Jan 22.

引用本文的文献

1
Associations between FOXO1 expression in tissue, the pathological characteristics of colorectal cancer, and patient survival.组织中FOXO1表达、结直肠癌病理特征与患者生存率之间的关联。
Int J Colorectal Dis. 2025 May 2;40(1):105. doi: 10.1007/s00384-025-04896-9.
2
Identification and Experimental Verification of Potential Immune Cell-Associated Gene Biomarkers in Human Intervertebral Disc Degeneration.人椎间盘退变中潜在免疫细胞相关基因生物标志物的鉴定与实验验证
J Pain Res. 2025 Feb 26;18:993-1007. doi: 10.2147/JPR.S505859. eCollection 2025.
3
Role of long non-coding RNAs and natural products in prostate cancer: insights into key signaling pathways.
长链非编码RNA和天然产物在前列腺癌中的作用:对关键信号通路的见解
Funct Integr Genomics. 2025 Jan 17;25(1):16. doi: 10.1007/s10142-025-01526-z.
4
14-3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer.14-3-3ε:一种具有复杂生理功能但在癌症治疗方面具有潜在前景的蛋白质。
Cell Commun Signal. 2024 Jan 26;22(1):72. doi: 10.1186/s12964-023-01420-w.
5
Histone methyltransferase SUV39H2 regulates apoptosis and chemosensitivity in prostate cancer through AKT/FOXO signaling pathway.组蛋白甲基转移酶 SUV39H2 通过 AKT/FOXO 信号通路调节前列腺癌细胞的凋亡和化疗敏感性。
Med Oncol. 2024 Jan 3;41(2):44. doi: 10.1007/s12032-023-02252-x.
6
N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer.N6-甲基腺苷修饰的长链非编码 RNA 特征可用于前列腺癌生化复发的分层。
Hum Genet. 2024 Jul;143(7):857-874. doi: 10.1007/s00439-023-02603-8. Epub 2023 Sep 27.
7
Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer.长链非编码RNA在前列腺癌发病机制、诊断及治疗中的重要性。
Front Oncol. 2023 Mar 21;13:1123101. doi: 10.3389/fonc.2023.1123101. eCollection 2023.
8
Long Noncoding RNAs and Circular RNAs Regulate AKT and Its Effectors to Control Cell Functions of Cancer Cells.长链非编码 RNA 和环状 RNA 通过调控 AKT 及其效应物来控制癌细胞的细胞功能。
Cells. 2022 Sep 20;11(19):2940. doi: 10.3390/cells11192940.
9
Annotation and functional characterization of long noncoding RNAs deregulated in pancreatic adenocarcinoma.注释和功能分析胰腺腺癌中失调的长非编码 RNA。
Cell Oncol (Dordr). 2022 Jun;45(3):479-504. doi: 10.1007/s13402-022-00678-5. Epub 2022 May 14.
10
Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization.前列腺癌放射组学——从成像到分子特征分析。
Int J Mol Sci. 2021 Sep 15;22(18):9971. doi: 10.3390/ijms22189971.